Stock Events

Stock Events

Immunovia AB 

$0.004740
7
+$0.00+0%Thursday 21:00

Statistics

Day High
0.15
Day Low
0.15
52W High
0.15
52W Low
0.00474
Volume
325
Avg. Volume
62
Mkt Cap
3.19M
P/E Ratio
-
Dividend Yield
-
Dividend
-

Upcoming

Earnings

Feb 11Expected
Q1 2025
Q2 2025
Q3 2025
Q1 2026
Q2 2026
Q3 2026
Next
-0.01
-0.01
-0
-0
Expected EPS
-0.0013484352
Actual EPS
N/A

Financials

-20,860.49%Profit Margin
Unprofitable
2020
2021
2022
2023
2024
2025
72,583.2Revenue
-15.14MNet Income

People Also Follow

This list is based on the watchlists of people on Stock Events who follow IMMVF. It's not an investment recommendation.
NVIDIA
2
NVDA
Coinbase Global
2
COIN
SAAB AB
2
SAAB-B.ST

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.
Guardant Health
GH
Mkt Cap23.99B
Guardant Health provides liquid biopsy tests for cancer diagnostics, overlapping with Immunovia's focus on early cancer detection using blood-based biomarkers.
Roche
RHHBY
Mkt Cap334.28B
Roche Holding AG develops diagnostic tools and technologies for detecting various diseases including cancer, similar to Immunovia's diagnostic solutions.
Illumina
ILMN
Mkt Cap35.63B
Illumina, Inc. offers genomic sequencing solutions used in cancer and other health diagnostics, competing in the broader market of molecular diagnostics.
Qiagen NV
QGEN
Mkt Cap10.37B
Qiagen N.V. provides sample and assay technologies for molecular diagnostics, competing with Immunovia in the field of precision medicine and diagnostics.
Quest Diagnostics
DGX
Mkt Cap27.79B
Quest Diagnostics incorporates advanced diagnostics for conditions including cancer, directly competing with Immunovia's diagnostic tests.
Bio-Rad Laboratories
BIO
Mkt Cap9.95B
Bio-Rad Laboratories, Inc. specializes in clinical diagnostics and life science research, offering products that compete in the diagnostics market.
Fulgent Genetics
FLGT
Mkt Cap567.37M
Fulgent Genetics, Inc. focuses on genetic testing to detect cancer and other diseases, competing with Immunovia's genomic and proteomic testing approaches.
Myriad Genetics
MYGN
Mkt Cap607.38M
Myriad Genetics, Inc. provides molecular diagnostic tests that assess the risk of developing cancer, competing with Immunovia's focus on early detection and risk assessment.

About

Immunovia AB (publ), a diagnostic company, develops blood diagnostic for detecting pancreatic cancer in Sweden. It also focuses on the development and commercialization of blood-based testing to detect proteins and antibodies that indicate pancreatic cancer in an individual. Immunovia AB (publ) was incorporated in 2007 and is headquartered in Lund, Sweden.
Show More
CEO
Jeff Borcherding
Employees
13
Country
Sweden
ISIN
SE0006091997
WKN
000A2AG0F

Listings

MU
DE
1YR.MU
LSE
GB
0G8X.LSE
ST
SE
IMMNOV.ST
F
DE
1YR.F

0 Comments

Share your thoughts

FAQs

What is Immunovia AB stock price today?▼
The current price of IMMVF is $0.00 USD — it has increased by +0% in the past 24 hours. Watch Immunovia AB stock price performance more closely on the chart.
What is Immunovia AB stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on OTC Link exchange Immunovia AB stocks are traded under the ticker IMMVF.
Is Immunovia AB stock price growing?▼
IMMVF stock has fallen by -52.6% compared to the previous week, the month change is a -52.6% fall, over the last year Immunovia AB has showed a -86.1% decrease.
What is Immunovia AB market cap?▼
Today Immunovia AB has the market capitalization of 3.19M
When is the next Immunovia AB earnings date?▼
Immunovia AB is going to release the next earnings report on February 11, 2027.
What were Immunovia AB earnings last quarter?▼
IMMVF earnings for the last quarter are -0 USD per share, whereas the estimation was -0 USD resulting in a +0% surprise. The estimated earnings for the next quarter are N/A USD per share.
What is Immunovia AB revenue for the last year?▼
Immunovia AB revenue for the last year amounts to 72,583.2 USD.
What is Immunovia AB net income for the last year?▼
IMMVF net income for the last year is -15.14M USD.
How many employees does Immunovia AB have?▼
As of November 8, 2026, the company has 13 employees.
In which sector is Immunovia AB located?▼
Immunovia AB operates in the Health & Wellness sector.
When did Immunovia AB complete a stock split?▼
The last stock split for Immunovia AB was on February 3, 2026 with a ratio of 1:100.
Where is Immunovia AB headquartered?▼
Immunovia AB is headquartered in Lund, Sweden.